These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 27097568)

  • 1. More than a black box of rehabilitation: Characterizing therapy programmes following botulinum toxin injections for spasticity in adults with stroke.
    Demetrios M; Brand C; Louie J; Khan F
    J Rehabil Med; 2016 Apr; 48(5):426-34. PubMed ID: 27097568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M; Gorelik A; Louie J; Brand C; Baguley IJ; Khan F
    J Rehabil Med; 2014 Sep; 46(8):730-7. PubMed ID: 25073939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Samizo Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2017 Jun; 127(6):469-478. PubMed ID: 27256591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
    Kakuda W; Abo M; Momosaki R; Yokoi A; Fukuda A; Ito H; Tominaga A; Umemori T; Kameda Y
    Eur J Phys Rehabil Med; 2012 Mar; 48(1):47-55. PubMed ID: 22071503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
    Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
    Lagalla G; Danni M; Reiter F; Ceravolo MG; Provinciali L
    Am J Phys Med Rehabil; 2000; 79(4):377-84; quiz 391-4. PubMed ID: 10892624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
    Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of additional rehabilitation following botulinum toxin-A on upper limb activity in chronic stroke: the InTENSE randomised trial.
    Lannin NA; Ada L; English C; Ratcliffe J; Faux S; Palit M; Gonzalez S; Olver J; Schneider E; Crotty M; Cameron ID
    BMC Neurol; 2022 Apr; 22(1):154. PubMed ID: 35468766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
    Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
    Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.